Evidence map›Paper›PMID 25739099›Full record

ArticlePloS one2015

A rapid molecular approach for chromosomal phasing.

John F Regan, Nolan Kamitaki, Tina Legler, Samantha Cooper, Niels Klitgord, George Karlin-Neumann, Catherine Wong, Shawn Hodges, Ryan Koehler, Svilen Tzonev and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Article
  3. Digital PCR linkage analysis resolvesMicrobiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in pharmacology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

John F ReganDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
Nolan KamitakiDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Cambridge, Massachusetts, United States of America.
Tina LeglerDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
Samantha CooperDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
Niels KlitgordDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
George Karlin-NeumannDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
Catherine WongDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Shawn HodgesDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
Ryan KoehlerDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
Svilen TzonevDigital Biology Center, Bio-Rad Laboratories, Pleasanton, California, United States of America.
Steven A McCarrollDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Cambridge, Massachusetts, United States of America.
Bio-Rad (United States) · USHarvard University · USStanley Center for Psychiatric Research

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining the chromosomal phase of pairs of sequence variants - the arrangement of specific alleles as haplotypes - is a routine challenge in molecular genetics. Here we describe Drop-Phase, a molecular method for quickly ascertaining the phase of pairs of DNA sequence variants (separated by 1-200 kb) without cloning or manual single-molecule dilution. In each Drop-Phase reaction, genomic DNA segments are isolated in tens of thousands of nanoliter-sized droplets together with allele-specific fluorescence probes, in a single reaction well. Physically linked alleles partition into the same droplets, revealing their chromosomal phase in the co-distribution of fluorophores across droplets. We demonstrated the accuracy of this method by phasing members of trios (revealing 100% concordance with inheritance information), and demonstrate a common clinical application by phasing CFTR alleles at genomic distances of 11-116 kb in the genomes of cystic fibrosis patients. Drop-Phase is rapid (requiring less than 4 hours), scalable (to hundreds of samples), and effective at long genomic distances (200 kb).

Indexed as

AlgorithmsCell LineChromosomesGenomicsHumansPolymorphism, Single NucleotideSequence Analysis, DNATime Factors

Identifiers

PMID25739099
PMCPMC4349636
OpenAlexW1973381130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.